Cochrane Database of Systematic Reviews 2012
DOI: 10.1002/14651858.cd008427.pub2
|View full text |Cite|
|
Sign up to set email alerts
|

Interventions for fatigue and weight loss in adults with advanced progressive illness

Abstract: Background Objectives Methods Main results Authors' conclusions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
69
0
3

Year Published

2013
2013
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 97 publications
(75 citation statements)
references
References 92 publications
(8 reference statements)
1
69
0
3
Order By: Relevance
“…It is vital that researchers separately report outcome measures in a subgroup analysis for participants with advanced illness, even if the findings are statistically nonsignificant. Adopting uniform reporting mechanisms for outcome measures of fatigue and weight loss would also provide an opportunity for meta-analyses of smaller studies 70 .…”
Section: Implications For Researchmentioning
confidence: 99%
“…It is vital that researchers separately report outcome measures in a subgroup analysis for participants with advanced illness, even if the findings are statistically nonsignificant. Adopting uniform reporting mechanisms for outcome measures of fatigue and weight loss would also provide an opportunity for meta-analyses of smaller studies 70 .…”
Section: Implications For Researchmentioning
confidence: 99%
“…Nutritional supplementation supports weight gain, respiratory muscle strength and overall health-related quality of life in malnourished patients. Fatigue may be reduced by self-management education, pulmonary rehabilitation, nutritional support and mind-body interventions [81,82]. Prediction of 6-month survival in patients with end-stage COPD is unreliable and therefore early discussion of advance care planning is recommended [83].…”
Section: Non-pharmacologic Therapiesmentioning
confidence: 99%
“…[6]. В 2 из этих исследований проводилось сравнение амантадина с други-ми препаратами, а в 3 -сравнение с плацебо.…”
Section: Multiple Sclerosis (Ms)-related Fatigue Is Encountered In 75unclassified
“…Впоследствии, согласно данным литературы, было показа-но действие препарата на усталость и потерю массы у взрослых пациентов. Амантадин может облегчить симпто-мы усталости у некоторых пациентов с РС, хотя его поло-жительное влияние в далеко зашедших стадиях заболева-ния не доказано [6].…”
Section: Multiple Sclerosis (Ms)-related Fatigue Is Encountered In 75unclassified
See 1 more Smart Citation